Catalyst Wire Dossier Catalyst Wire Dossier

TW1025

· Meriyana Bio Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TW1025, covering 2016-10-21 to 2016-10-21. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate the Safety Profile and Ability of TW1025 Oral Solution to Decrease Fatigue [Phase 2]

See pricing